Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891531289> ?p ?o ?g. }
- W2891531289 endingPage "131" @default.
- W2891531289 startingPage "120" @default.
- W2891531289 abstract "Emerging hallmark of cancer is reprogrammed cellular metabolism, increased glycolytic metabolism is physiological characteristic of human malignant neoplasms. Saponin monomer 13 of the dwarf lilyturf tuber (DT-13) is the main steroidal saponin from Liriopes Radix, which has been reported to exert anti-inflammation and anti-tumor activities but low toxicity to normal tissue. However, the effect of DT-13 on metabolism process is still unclear. This study aims to characterize the role of DT-13 in glucose metabolism in colorectal cancer cells, and investigate whether the metabolism process is involved in the anti-cancer response of DT-13. Colony formation assay was employed to determine anti-proliferative effect induced by DT-13 at 2.5, 5, 10 μM. Apoptosis and cell cycle arrest were detected by Annexin V/PI staining and PI staining, respectively. Genetic inhibition of glycolytic metabolism was carried out by knockdown of GLUT1. Orthotopic implantation mouse model of colorectal cancer was used to assess in vivo antitumor effect of DT-13 (0.625, 1.25, 2.5 mg/kg). The chemoprevention effect of DT-13 (10mg/kg) was evaluated by using C57BL/6J APCmin mice model. Glycolytic-related key enzymes and AMPK pathway were detected by using quantitative real-time PCR, western blotting, and immunohistochemical staining. Our results showed that cell proliferation was significantly inhibited by DT-13 in a dose-dependent manner. DT-13 inhibited glucose uptake, ATP generation, and reduced lactate production. Furthermore, DT-13 remarkably inhibited GLUT1 expression in both mRNA and protein levels. Knocking down of GLUT1 led to reduced inhibition of glucose uptake after DT-13 treatment. Moreover, deletion of GLUT1 decreased inhibitory ratio of DT-13 on cancer growth. Orthotopic implantation mouse model of colorectal cancer further confirmed that DT-13 inhibited colorectal cancer growth via blocking GLUT1 in vivo. In addition, C57BL/6J APCmin mice model revealed that DT-13 dramatically reduced the total number of spontaneous adenomas in intestinal, which further confirmed the anti-tumor activity of DT-13 in colorectal cancer. Furthermore, the mechanistically investigation showed DT-13 activated AMPK and inhibited m-TOR to block cancer growth in vitro. DT-13 is a potent anticancer agent for colorectal cancer." @default.
- W2891531289 created "2018-09-27" @default.
- W2891531289 creator A5009198510 @default.
- W2891531289 creator A5020122876 @default.
- W2891531289 creator A5025681569 @default.
- W2891531289 creator A5047305117 @default.
- W2891531289 creator A5058555021 @default.
- W2891531289 creator A5058775119 @default.
- W2891531289 creator A5064049313 @default.
- W2891531289 creator A5080610834 @default.
- W2891531289 creator A5083095344 @default.
- W2891531289 creator A5087327887 @default.
- W2891531289 creator A5087821382 @default.
- W2891531289 creator A5090430064 @default.
- W2891531289 date "2019-02-01" @default.
- W2891531289 modified "2023-10-14" @default.
- W2891531289 title "DT-13 inhibited the proliferation of colorectal cancer via glycolytic metabolism and AMPK/mTOR signaling pathway" @default.
- W2891531289 cites W1959643760 @default.
- W2891531289 cites W1971078715 @default.
- W2891531289 cites W1971967608 @default.
- W2891531289 cites W1974169241 @default.
- W2891531289 cites W1981421409 @default.
- W2891531289 cites W2004393499 @default.
- W2891531289 cites W2007843828 @default.
- W2891531289 cites W2016752484 @default.
- W2891531289 cites W2018553282 @default.
- W2891531289 cites W2029504119 @default.
- W2891531289 cites W2058875473 @default.
- W2891531289 cites W2071697240 @default.
- W2891531289 cites W2080680563 @default.
- W2891531289 cites W2086942943 @default.
- W2891531289 cites W2089214430 @default.
- W2891531289 cites W2134433047 @default.
- W2891531289 cites W2136607709 @default.
- W2891531289 cites W2141129148 @default.
- W2891531289 cites W2145265436 @default.
- W2891531289 cites W2155598285 @default.
- W2891531289 cites W2162868196 @default.
- W2891531289 cites W2163188200 @default.
- W2891531289 cites W2331697008 @default.
- W2891531289 cites W2336409096 @default.
- W2891531289 cites W2337094551 @default.
- W2891531289 cites W2396345681 @default.
- W2891531289 cites W2443371189 @default.
- W2891531289 cites W2472130293 @default.
- W2891531289 cites W2534442878 @default.
- W2891531289 cites W2559934684 @default.
- W2891531289 cites W2587331820 @default.
- W2891531289 cites W2595157904 @default.
- W2891531289 cites W2611699738 @default.
- W2891531289 cites W2612249196 @default.
- W2891531289 cites W2618572519 @default.
- W2891531289 cites W2620066667 @default.
- W2891531289 cites W2625418525 @default.
- W2891531289 cites W2732904562 @default.
- W2891531289 cites W2750975167 @default.
- W2891531289 cites W2761502562 @default.
- W2891531289 cites W2766250201 @default.
- W2891531289 cites W2917837889 @default.
- W2891531289 cites W4235379005 @default.
- W2891531289 doi "https://doi.org/10.1016/j.phymed.2018.09.003" @default.
- W2891531289 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30668361" @default.
- W2891531289 hasPublicationYear "2019" @default.
- W2891531289 type Work @default.
- W2891531289 sameAs 2891531289 @default.
- W2891531289 citedByCount "30" @default.
- W2891531289 countsByYear W28915312892019 @default.
- W2891531289 countsByYear W28915312892020 @default.
- W2891531289 countsByYear W28915312892021 @default.
- W2891531289 countsByYear W28915312892022 @default.
- W2891531289 countsByYear W28915312892023 @default.
- W2891531289 crossrefType "journal-article" @default.
- W2891531289 hasAuthorship W2891531289A5009198510 @default.
- W2891531289 hasAuthorship W2891531289A5020122876 @default.
- W2891531289 hasAuthorship W2891531289A5025681569 @default.
- W2891531289 hasAuthorship W2891531289A5047305117 @default.
- W2891531289 hasAuthorship W2891531289A5058555021 @default.
- W2891531289 hasAuthorship W2891531289A5058775119 @default.
- W2891531289 hasAuthorship W2891531289A5064049313 @default.
- W2891531289 hasAuthorship W2891531289A5080610834 @default.
- W2891531289 hasAuthorship W2891531289A5083095344 @default.
- W2891531289 hasAuthorship W2891531289A5087327887 @default.
- W2891531289 hasAuthorship W2891531289A5087821382 @default.
- W2891531289 hasAuthorship W2891531289A5090430064 @default.
- W2891531289 hasConcept C109156525 @default.
- W2891531289 hasConcept C134018914 @default.
- W2891531289 hasConcept C17093226 @default.
- W2891531289 hasConcept C184235292 @default.
- W2891531289 hasConcept C185592680 @default.
- W2891531289 hasConcept C190283241 @default.
- W2891531289 hasConcept C20251656 @default.
- W2891531289 hasConcept C2777866211 @default.
- W2891531289 hasConcept C2777952866 @default.
- W2891531289 hasConcept C2778616655 @default.
- W2891531289 hasConcept C2779306644 @default.
- W2891531289 hasConcept C2780124434 @default.
- W2891531289 hasConcept C502942594 @default.
- W2891531289 hasConcept C55493867 @default.